BRKR logo

Bruker Corporation (BRKR)

$53.41

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on BRKR

Market cap

$8.12B

EPS

-0.16

P/E ratio

--

Price to sales

2.41

Dividend yield

0.374%

Beta

1.168369

Price on BRKR

Previous close

$54.46

Today's open

$55

Day's range

$51.81 - $56.22

52 week range

$28.53 - $64.64

Profile about BRKR

CEO

Frank H. Laukien

Employees

11396

Headquarters

Billerica, MA

Exchange

Nasdaq Global Select

Shares outstanding

151941144

Issue type

Common Stock

BRKR industries and sectors

Healthcare

Biotechnology & Life Sciences

News on BRKR

Bruker Corporation (BRKR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Bruker Corporation (BRKR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

news source

Seeking Alpha • a day ago

news preview

Bruker Announces $500 Million in Multi-Year Orders from Two Global Healthcare Companies for Supply of High-Performance Superconductors for MRI

HANAU, Germany--(BUSINESS WIRE)---- $BRKR #BRKR--The Bruker Energy & Supercon Technologies (BEST) division, a segment of Bruker Corporation (Nasdaq: BRKR), today announced two multi-year supply agreements for Bruker's latest superconductors, which are used by global radiology companies to build their next generations of magnetic resonance imaging (MRI) magnets. The combined order value of the two agreements is approximately $500 million in expected future BEST revenues, with different agreement duration pe.

news source

Business Wire • Jan 9, 2026

news preview

Bruker: Attractive Valuation Ahead Of An Earnings Inflection

Bruker is positioned for strong FY26 growth, driven by backlog, end-market recovery, and high-margin semiconductor orders. BRKR should see margin expansion from cost reductions, improved pricing, favorable mix, and easing M&A-related dilution. The stock trades at a significant discount to historical and peer valuations, despite expectations of double-digit EPS growth from FY26 onward.

news source

Seeking Alpha • Jan 9, 2026

news preview

Bruker Consolidates Ownership of TOFWERK in Expansion of Mass Spectrometry Portfolio into New Applied Markets

THUN, Switzerland--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of an additional 60% ownership stake in TOFWERK AG, a Switzerland-based innovator in ultra-fast time-of-flight (TOF) mass spectrometry technology for small molecule applied markets, consolidating Bruker's ownership to 100%. The transaction adds ultra-fast TOF-MS technology for small-molecule markets, including atmospheric chemistry research, air quality monitoring, exposomics, foods, flavors &a.

news source

Business Wire • Jan 8, 2026

news preview

Bruker Corporation to Present at the J.P. Morgan Healthcare Conference

BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 45th annual J.P. Morgan Healthcare Conference in San Francisco. Senior leadership will present on behalf of the Company on Monday, January 12th, 2026 at 9:00 AM Pacific Standard Time. A live audio webcast of the presentation will be available on the Investor Relations section of the Company's website at https://ir.bruker.com. A replay of the presentation will be posted in the “Events.

news source

Business Wire • Jan 7, 2026

news preview

Why a $30 Million Bruker Stock Trim Matters Amid an 18% Slide

Utah-based Grandeur Peak Global Advisors sold 709,697 shares of Bruker in the third quarter. The estimated position value declined by $29.54 million from the previous period.

news source

The Motley Fool • Dec 26, 2025

news preview

Should You Continue to Hold BRKR Stock in Your Portfolio?

Bruker's innovation pipeline and acquisitions support long-term growth, but macro pressures and funding risks cloud the stock's near-term outlook.

news source

Zacks Investment Research • Dec 26, 2025

news preview

RI Research Instruments Announces Major Orders for Enabling Technology for the Gamma-Ray Source of the Extreme Light Infrastructure (ELI)

BERGISCH GLADBACH, Germany--(BUSINESS WIRE)---- $BRKR #BRKR--RI Research Instruments, a company that is majority-owned by Bruker Corporation (Nasdaq: BRKR), today announced orders for key components and enabling subsystems for the research gamma ray source of the Extreme Light Infrastructure – Nuclear Physics (ELI-NP) at the Horia Hulubei National Institute of Physics and Nuclear Engineering (IFIN-HH) in Romania. The total value of these ELI contracts is approximately €35 million (more than USD $40 million), w.

news source

Business Wire • Dec 22, 2025

news preview

Bruker Corporation (BRKR) Presents at 53rd Annual Nasdaq Investor Conference Transcript

Bruker Corporation (BRKR) Presents at 53rd Annual Nasdaq Investor Conference Transcript

news source

Seeking Alpha • Dec 10, 2025

news preview

Bruker Announces Orders for High-Performance Magnetic Resonance Systems for Materials and Life-Science Research from Leading European Institutions

ETTLINGEN, Germany--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced several significant European orders for high-performance magnetic resonance systems from three leading research institutions in France and Germany: In the summer, École Normale Supérieure (ENS-PSL) in Paris, France ordered a novel NMR relaxometry system to be used alongside its recently acquired 900 MHz NMR spectrometer. This unique capability will empower the investigation of the molecular dynamics of protei.

news source

Business Wire • Dec 10, 2025

news preview

¹ Disclosures

Get started with M1

Invest in Bruker Corporation

Open an M1 investment account to buy and sell Bruker Corporation commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in BRKR on M1